Best Momentum Stock to Buy for March 4th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 4th:

BrightSpring Health Services, Inc. BTSG: This parent company of healthcare service lines which, provide complementary home- and community-based pharmacy and provider health solutions for complex populations in need of specialized and/or chronic care, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days.

BrightSpring Health Services, Inc. Price and Consensus

BrightSpring Health Services, Inc. price-consensus-chart | BrightSpring Health Services, Inc. Quote

BrightSpring Health Services' shares gained 15.7% over the last three month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.

BrightSpring Health Services, Inc. Price

BrightSpring Health Services, Inc. price | BrightSpring Health Services, Inc. Quote

XP XP: This technology-driven financial services platform which offers financial products and services primarily in Brazil, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.

XP Inc. Price and Consensus

XP Inc. price-consensus-chart | XP Inc. Quote

XP’s shares gained 3.2% over the last three month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.

XP Inc. Price

XP Inc. price | XP Inc. Quote

Catalyst Pharmaceuticals CPRX: This commercial-stage biopharmaceutical company, which is focused on the development and commercialization of therapies targeting rare and difficult-to-treat diseases, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.

Catalyst Pharmaceuticals, Inc. Price and Consensus

Catalyst Pharmaceuticals, Inc. price-consensus-chart | Catalyst Pharmaceuticals, Inc. Quote

Catalyst Pharmaceuticals shares gained 3.6% over the last three month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.

Catalyst Pharmaceuticals, Inc. Price

Catalyst Pharmaceuticals, Inc. price | Catalyst Pharmaceuticals, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here

Free Report: Profiting from the 2nd Wave of AI Explosion

The next phase of the AI explosion is poised to create significant wealth for investors, especially those who get in early. It will add literally trillion of dollars to the economy and revolutionize nearly every part of our lives.

Investors who bought shares like Nvidia at the right time have had a shot at huge gains.

But the rocket ride in the "first wave" of AI stocks may soon come to an end. The sharp upward trajectory of these stocks will begin to level off, leaving exponential growth to a new wave of cutting-edge companies.

Zacks' AI Boom 2.0: The Second Wave report reveals 4 under-the-radar companies that may soon be shining stars of AI’s next leap forward.

Access AI Boom 2.0 now, absolutely free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Catalyst Pharmaceuticals, Inc. (CPRX): Free Stock Analysis Report

XP Inc. (XP): Free Stock Analysis Report

BrightSpring Health Services, Inc. (BTSG): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research